Bottmingen, Switzerland

Constantinos G Panousis


Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • Bottmingen, CH (2009 - 2012)
  • Lyndhurst, NJ (US) (2011 - 2012)

Company Filing History:


Years Active: 2009-2012

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Constantinos G Panousis: Pioneering Innovator from Bottmingen

Introduction: Constantinos G Panousis stands as a beacon of innovation in Bottmingen, CH, inspiring aspiring inventors and leaving a lasting impact on the world of inventions. His relentless pursuit of innovation continues to shape the technological landscape, making him a true pioneer in his field.

Latest Patents: Constantinos G Panousis has a total of 8 patents to his name, showcasing his expertise and contributions to the field of inventions. His latest patents include groundbreaking discoveries such as Pyrazinecarboxamide derivatives as HDL-cholesterol raising agents, and 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents.

Career Highlights: Constantinos G Panousis is associated with Hoffmann-La Roche Inc., a renowned pharmaceutical company known for its innovative research and development in the healthcare industry. His work within the company has led to significant advancements in the treatment and prophylaxis of diseases related to dyslipidemia.

Collaborations: Throughout his career, Constantinos G Panousis has collaborated with esteemed coworkers such as Stephan Roever and Henrietta Dehmlow. Together, they have worked on various projects that have pushed the boundaries of innovation in the pharmaceutical sector.

Conclusion: In conclusion, Constantinos G Panousis stands as a testament to the power of innovation and dedication in the world of inventions. His work continues to inspire aspiring inventors around the globe, and his contributions have left a profound impact on the field of healthcare and pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…